Skip to main content
ADVANCED SEARCH
Log in
Top
Digestive Diseases and Sciences
Published in:

05-09-2022 | Artificial Intelligence | Editorial

Polyp Fact or Polyp Fiction: Endoscopic Identification of Polyps Using Established Criteria to Improve the Quality of Endoscopic Evaluation and Cost Effectiveness

Authors: Ihsan Al Bayati, Sarah Al Obaidi, Mohammed Bashashati

Published in: Digestive Diseases and Sciences | Issue 2/2023

Login to get access

Excerpt

The primary means of colorectal cancer prevention is resection of premalignant colonic polyps during screening and surveillance colonoscopies. The downtrend in the incidence and mortality of colon cancer in the USA [1] is thought to be related to the implementation of colon cancer screening programs, the increased quality of endoscopic examination, and the development of technologies and instrumentation aimed at improving polyp detection and resection [2, 3]. …
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Polyp Fact or Polyp Fiction: Endoscopic Identification of Polyps Using Established Criteria to Improve the Quality of Endoscopic Evaluation and Cost Effectiveness
Authors
Ihsan Al Bayati
Sarah Al Obaidi
Mohammed Bashashati
Publication date
05-09-2022
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 2/2023
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-022-07645-y

Other articles of this Issue 2/2023

Impact of Interferon-Free Direct-Acting Antivirals on the Incidence of Extrahepatic Malignancies in Patients with Chronic Hepatitis C

Histologic Severity of Nonalcoholic Fatty Liver Disease Associates with Reduced Bone Mineral Density in Children

Upadacitinib Is Safe and Effective for Crohn’s Disease: Real-World Data from a Tertiary Center

Clinical Efficacy of Tandospirone on Functional Dyspepsia Patients with Anxiety: A Randomized, Placebo-Controlled Study

Azathioprine Withdrawal Is Cost-Effective in Patients with Crohn’s Disease in Remission on Infliximab and Azathioprine

Response to Ursodeoxycholic Acid May Be Assessed Earlier to Allow Second-Line Therapy in Patients with Unresponsive Primary Biliary Cholangitis

Innovations in AML: insights and practical guidance

Hear directly from acute myeloid leukemia experts in this vodcast series focussing on innovations in molecular testing, emerging therapies, and targeted treatments, and get practical advice for improving the care of your patients with relapsed or refractory disease.

Supported by:
  • Rigel Pharmaceuticals, Inc.
Developed by: Springer Health+ IME
Learn more

ADA 2025

Unlock your free and exclusive access to the latest news from the American Diabetes Association’s 85th Scientific Sessions.

Read more
Image Credits